Patients with postacute sequelae of SARS-CoV-2 infection also have circulatory impairment, myalgic encephalomyelitis/chronic fatigue
THURSDAY, Dec. 9, 2021 (HealthDay News) — For patients with postacute sequelae of severe acute respiratory syndrome-coronavirus 2 infection (PASC), circulatory impairment, abnormal ventilatory patterns, and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are common, according to a study published in the December issue of JACC: Heart Failure.
Noting that about 20 percent of patients who recover from COVID-19 remain symptomatic, Donna M. Mancini, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues performed cardiopulmonary exercise testing and symptom assessment for ME/CFS in 41 patients (18 men and 23 women) with PASC after COVID-19.
The researchers found that 58.5 percent of the patients had a peak oxygen consumption (VO2) <80 percent of predicted, all of whom had a circulatory limitation to exercise. Of the 17 patients with normal peak VO2, 15 had ventilatory abnormalities, including peak respiratory rate >55 or dysfunctional breathing (three and 12, respectively). Eighty-eight percent of the whole cohort had ventilatory abnormalities with dysfunctional breathing, increased slope of minute ventilation to carbon dioxide production, and/or hypocapnia end tidal pressure of carbon dioxide. The criteria for ME/CFS were met by 19 of the patients.
“These findings suggest that in a subgroup of long haulers, hyperventilation and/or dysfunctional breathing may underlie their symptoms,'” Mancini said in a statement. “This is important as these abnormalities may be addressed with breathing exercises or ‘retraining.”
Abstract/Full Text (subscription or payment may be required)
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis
Cognitive, Manual Impairment Tied to Unacceptable Inhaler Technique
Vitamin A, D May Aid Asthma Outcomes
Consensus Statements Developed for Rheumatoid Arthritis-Linked Interstitial Lung Disease
Exposure to Air Pollutants Linked to Increased RA Disease Activity
Timing of JAK Initiation, Shingles Vaccine Administration Can Affect Outcomes in RA
Longer Persistence Seen With Upadacitinib Versus TNFi in Rheumatoid Arthritis
Mesothelioma Diagnoses and Deaths Still Increasing